Title |
Pharmacological interventions for borderline personality disorder
|
---|---|
Published in |
Cochrane database of systematic reviews, June 2010
|
DOI | 10.1002/14651858.cd005653.pub2 |
Pubmed ID | |
Authors |
Jutta Stoffers, Birgit A Völlm, Gerta Rücker, Antje Timmer, Nick Huband, Klaus Lieb |
Abstract |
Drugs are widely used in borderline personality disorder (BPD) treatment, chosen because of properties known from other psychiatric disorders ("off-label use"), mostly targeting affective or impulsive symptom clusters. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 22% |
Japan | 1 | 6% |
Australia | 1 | 6% |
Sao Tome and Principe | 1 | 6% |
Turkey | 1 | 6% |
Denmark | 1 | 6% |
Unknown | 9 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 14 | 78% |
Practitioners (doctors, other healthcare professionals) | 2 | 11% |
Scientists | 2 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 608 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Sweden | 2 | <1% |
United States | 2 | <1% |
Brazil | 1 | <1% |
New Zealand | 1 | <1% |
Canada | 1 | <1% |
Japan | 1 | <1% |
Mexico | 1 | <1% |
Unknown | 599 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 82 | 13% |
Student > Bachelor | 81 | 13% |
Researcher | 60 | 10% |
Student > Ph. D. Student | 56 | 9% |
Student > Doctoral Student | 51 | 8% |
Other | 122 | 20% |
Unknown | 156 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 212 | 35% |
Psychology | 105 | 17% |
Nursing and Health Professions | 37 | 6% |
Social Sciences | 22 | 4% |
Neuroscience | 13 | 2% |
Other | 51 | 8% |
Unknown | 168 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2022.
All research outputs
#1,453,385
of 25,775,807 outputs
Outputs from Cochrane database of systematic reviews
#3,073
of 13,139 outputs
Outputs of similar age
#4,230
of 97,438 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 75 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,139 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,438 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.